Vaccine's are tough. The lining of the lung is like our skin, it...

Vaccine's are tough. The lining of the lung is like our skin, it has a different immune system. We have never been successful in vaccine's for respiratory virus. It could take another 5-years for a vaccine with greater than 50% efficacy. In meantime the Covid-19 virus is here with us for a long time. Stem Cell therapies are proving in multiple anecdotal studies around the world to be the best available therapeutic for Covid-19 ARDS at present. Mesoblast has the most extensive IP / Patent portfolio covering MSC's. Also the exact same MSB therapy is being fast tracked by FDA and could be approved for GVHD by August, The timing is fortuitous. An sNDA can be done in a few weeks with the FDA. Mesoblast's RYONCIL could be one of the first fully approved therapies for Covid-19 ARDS. The FDA may require more supplemental data following approval, however the safety profile is second to none when you consider that Mesoblast have already dosed over 1,000 in different indications.